Patients with pneumonia may spend fewer days in the hospital if they are given steroids along with antibiotics and supportive care. That's the finding of a Mayo Clinic analysis of eight randomized-controlled clinical trials involving more than 1,100 patients. The results appear in the March issue of the Journal of Hospital Medicine.
"Given that the average hospital stay for community-acquired pneumonia can range from nine to 23 days, the prospect of speeding recovery, even by a day or two, is helpful," says co-author M. Rizwan Sohail, M., a Mayo infectious disease specialist.
Pneumonia is a major health risk, especially in the elderly, the very young and those with chronic lung diseases. Five percent to 15 percent of pneumonia patients die from it, depending on its severity and the treatment administered, recent studies report.
Mayo researchers reviewed eight clinical trials conducted from 2000 to 2011. Most of the research studied patients between 60 and 80. While steroid use didn't prevent deaths, for those who survived the pneumonia, it reduced their hospital stays an average of 1.21 days.
The researchers say that while the findings are significant, the data were not strong enough for them to recommend routine use of steroids for pneumonia patients; more study is needed. They add that continuing any steroids patients may already be taking is reasonable.
The study was led by Majid Shafiq, MD, a former Mayo Clinic researcher currently at Johns Hopkins University.
A similar, but unrelated study by A.R. Khan, MD, involving researchers at Mayo Clinic and other institutions, found that use of certain lipid-lowering medicines, commonly referred to as statins, may have a role in reducing the risk of developing community-acquired pneumonia and associated mortality. That study, published last month in PLOS ONE, reviewed 18 clinical trials. The evidence was considered less reliable due to design issues, bias and other factors in the original studies.
Vaccination remains the most powerful tool in infection prevention, researchers say. The Centers for Disease Control and Prevention (CDC)Â recommends that all adults 65 or older should receive the pneumonia vaccine and that anyone 19 or older with risk factors such as immune deficiency or chronic lung disease also should get it.
Â
Source: Mayo Clinic
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain
July 17th 2025A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.
What Lies Beneath: Why Borescopes Are Essential for Verifying Surgical Instrument Cleanliness
July 16th 2025Despite their smooth, polished exteriors, surgical instruments often harbor dangerous contaminants deep inside their lumens. At the HSPA25 and APIC25 conferences, Cori L. Ofstead, MSPH, and her colleagues revealed why borescopes are an indispensable tool for sterile processing teams, offering the only reliable way to verify internal cleanliness and improve sterile processing effectiveness to prevent patient harm.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.